In the name of God. Case presentation The 18 year old Iranian man previously diagnosed hemophilia… with family history of consanguinity presented for.

Slides:



Advertisements
Similar presentations
HAEMATOLOGY IN THE ICU – TAKE 2 Bryony Ross 22/2/2010.
Advertisements

The Basics of Hemophilia
J. Bormanis/ cg edits  When did it start ?  Dental history  Spontanous bruising  Bleeding at surgery  Bleeding into joints  Menstrual bleeding.
Bleeding Disorders For Surgeons
Bleeding and Thrombosis in Children Alice J. Cohen, M.D. Newark Beth Israel Medical Center.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Tests of Hemostasis Path 430/826 David Lillicrap Department of Pathology and Molecular Medicine Queen’s University, Kingston, Canada.
Bleeding and coagulation disorders
MLAB 1227: Coagulation Keri Brophy-Martinez
Hemophilia What is Hemophilia? Hemophilia is an inherited bleeding disorder in which there is a deficiency or lack of factor VIII or factor IX clotting.
C51 Coagulation. “Bleeding” VS “Coagulation” Vessels –Bleeding Time Blood cells: –Platelet(c60.ppt ) Number, function Coagulation –S(+)LAB(+) –S(-)LAB(
Approach to the Bleeding Patient
By: Bekim Ameti. Information On Hemophilia Hemophilia is the oldest known heredity bleeding disorder. Hemophilia has been known for thousands of years.
An Introduction to Haemophilia and related bleeding disorders M QARI, MD, FRCPA.
MISHA MAZHAR 2k10-NUST-BS-V&I-54.  Mutations in F8 or F9 genes.  Leads to lack of proteins made by these genes.  F8 responsible for making the blood.
Interactive Session on Clotting Profile Dr P T R Makuloluwa MBBS (Col), MD (Anaesthesiology), FRCA (Lond)
MLAB Coagulation Keri Brophy-Martinez
Hemophilia A By Marissa Miuccio.
General Approach of Haemostasis
VON WILLEBRAND DISEASE Nairobi, Kenya June 25, 2013.
Approach to Bleeding Disorders
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
Child with hematological dysfunction Emad Al Khatib, RN,MSN,CNS.
MIXING STUDIES General Approach of Haemostasis
Hemophilia Kelsy DeBrock & Max Appelblatt. Hemophilia Hemophilia is a bleeding disorder where it takes a long time for your blood to clot With Hemophilia,
Hemophilia Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is: Hemophilia is an X-linked congenital bleeding disorder.
Coagulation Disorder Jeopardy DdxClinicalLab Tests Manageme nt Miscellaneo us.
The Hemophilia Federation of America (HFA) is a national nonprofit organization that assists and advocates for the bleeding disorders community. MISSION.
SCREENING COAGULATION STUDIES When & when NOT to do them.
The Hemophilia Federation of America (HFA) is a national nonprofit organization that assists and advocates for the bleeding disorders community. MISSION.
February 4 th, The Child With Pain Single Joint Involvement Multiple Joint Involvement With Fever Septic arthritis/Osteomyelitis Sympathetic arthritis.
THE DISORDER: HEMOPHILIA How did it pass through to each generation. How can it be treated.
Factor VII Deficiency Diagnosis and Management
Molecular Genetics in the Von Willebrand disease Ghasem Rastegarlari.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Inherited bleeding disorder of primary hemostasis.
Von Willebrand’s Disease (vWD) Among women with unexplained menorrhagia.
Von Willebrand Disease
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
The Basics of Hemophilia. Hemostatic System Blood vessels Platelets Plasma coagulation system Proteolytic or Fibrinolytic system.
Tests of Hemostasis Path 430/826 David Lillicrap Department of Pathology and Molecular Medicine Queen’s University, Kingston, Canada.
Von Willebrand’s Disease. vWD Family of bleeding disorders Family of bleeding disorders Caused by a deficiency or an abnormality of von Willebrand Factor.
INHERITED DISORDERS OF COAGULATION von Willebrand Disease 1.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemophilia By: Olivia Holman, Oscar Sierras Jaimes and Daniel Barnett.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Congenital bleeding disorders
Approach To Bleeding Disorders In Neonates
Multiple choice questions
Hemophilia 2009.
Hemophilia Brandon Vilorio.
General Approach of Haemostasis
General Approach in Investigation of Hemostasis
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Introduction Discussion Case report References
Dr.Avinash Jadhao 10/6/ Vitamin K- Chemistry Vitamin K represents a group of lipophilic and hydrophobic vitamins. Three compounds have the biological.
Hemophilia.
Dr-Majid Qanavat Ped. Hematologist oncologist Isfahan university -1396
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
Hemophilia By: Renee Marie Alta.
The child with hematological dysfunction
Division of Clinical Hameatology
Principles of Coagulation Screening II
Dr. Festus Njuguna Moi University/MTRH
Hemostasis and Coagulation
Presentation transcript:

In the name of God

Case presentation The 18 year old Iranian man previously diagnosed hemophilia… with family history of consanguinity presented for excessive upper GI bleeding. Positive history prolonged bleeding after teeth extraction excessive bruising since childhood hemarthrosis, nose bleeding, Have been treated for episodes of excessive bleeding with FFP and F VIII during hospitalization.. His sister who experienced excessive bleeding menorhagia remained undiagnosed.

DIFFRENTIAL DIAGNOSIS LUPUS ANTICOAGULANT IF FVIII IS LOW OTHER INTITIES NEEDED TO BE CONCIDER BEFORE DIAGNOSE( HA) SAMPLE CLOTTED,WHOLE blood has BEEN KEPT ON ICE. VWD WHEN SEVER ENOUGH,CAUSE LOW FVIII. NORMAL VWF DONOT EXCLUDE TYPE 2N VWD WHICH IS CHARECTRIZED BY A FVIII:C 5-40% OF NORMAL.WHICH CAN BE DISTINGUISHED FROM (HA) BY INHERITANCE PATTERN,OR BY FVIII-BINDING ASSAY,GENETIC TESTS.

Coagulant factor deficiency Laboratory phenotype SevereModerateMild Coagulant activity Fibrinogenundetectable clot≤0,1 g/L>0,1 g/L FIIundetectable activity≤10%>10% FVundetectable activity10%≥10% FV+FVIII<20%20-40%>40% FVII<10%10-20%>20% FX<10%10-40%>40% FXIIIundetectable activity30%≥30% LEGEND SEVERE: coagulant activity associated with spontaneous major bleeding MODERATE : coagulant activity associated with mild spontaneous or triggered bleeding MILD: coagulant activity associated with a mostly asymptomatic disease course Based on Review of the literature ( ) and 4 databases/registries (EN-RBD; NARBDR; UKHCDO; Indian Tertiary Centre Registry) 1

Points to remember Clinical and family histories pertaining to bleeding abnormalities are extremely important in evaluating hereditary coagulation disorders. Further laboratory investigation is necessary when supposed diagnoses, family history, and results of initial laboratory studies are inconsistent. Although rae,F5F8D should be suspected in patients who claim to have hemophilia and have prolonged PT and a PTT, particularly if they are Middle Eastern heritage and/or family history of consanguinity.It is therefore necessary to include F5 and FVIII in testing for unexplained factor deficiencies in the setting of prolongation both PT and a PTT. IN patients with F5F8D and an acute bleeding episode, both F5 and F8 to be replaced. FFP must be given to replace F5 because no other source of F5 is currently available.

Points to remember Clinical and family histories pertaining to bleeding abnormalities are extremely important in evaluating hereditary coagulation disorders. Further laboratory investigation is necessary when supposed diagnoses, family history, and results of initial laboratory studies are inconsistent. Although rae,F5F8D should be suspected in patients who claim to have hemophilia and have prolonged PT and a PTT, particularly if they are Middle Eastern heritage and/or family history of consanguinity.It is therefore necessary to include F5 and FVIII in testing for unexplained factor deficiencies in the setting of prolongation both PT and a PTT. IN patients with F5F8D and an acute bleeding episode, both F5 and F8 to be replaced. FFP must be given to replace F5 because no other source of F5 is currently available.